<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37275906</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>No genetic causal association between systemic lupus erythematosus and COVID-19.</ArticleTitle><Pagination><StartPage>1183570</StartPage><MedlinePgn>1183570</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1183570</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1183570</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Emerging evidence suggests an increased prevalence of coronavirus disease 2019 (COVID-19) in patients with systemic lupus erythematosus (SLE), the prototype of autoimmune disease, compared to the general population. However, the conclusions were inconsistent, and the causal relationship between COVID-19 and SLE remains unknown.</AbstractText><AbstractText Label="METHODS">In this study, we aimed to evaluate the bidirectional causal relationship between COVID-19 and SLE using bidirectional Mendelian randomization (MR) analysis, including MR-Egger, weighted median, weighted mode, and the inverse variance weighting (IVW) method.</AbstractText><AbstractText Label="RESULTS">The results of IVW showed a negative effect of SLE on severe COVID-19 (OR&#xa0;=&#xa0;0.962, <i>p</i>&#xa0;=&#xa0;0.040) and COVID-19 infection (OR&#xa0;=&#xa0;0.988, <i>p</i>&#xa0;=&#xa0;0.025), which disappeared after Bonferroni correction. No causal effect of SLE on hospitalized COVID-19 was observed (OR&#xa0;=&#xa0;0.983, <i>p</i>&#xa0;=&#xa0;0.148). In the reverse analysis, no causal effects of severe COVID-19 infection (OR&#xa0;=&#xa0;1.045, <i>p</i>&#xa0;=&#xa0;0.664), hospitalized COVID-19 (OR&#xa0;=&#xa0;0.872, <i>p</i>&#xa0;=&#xa0;0.109), and COVID-19 infection (OR&#xa0;=&#xa0;0.943, <i>p</i>&#xa0;=&#xa0;0.811) on SLE were found.</AbstractText><AbstractText Label="CONCLUSION">The findings of our bidirectional causal inference analysis did not support a genetically predicted causal relationship between SLE and COVID-19; thus, their association observed in previous observational studies may have been caused by confounding factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Xu, Wang, Fang, Chen, Yang, Shuai and Tao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shu-Zhen</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhi-Xin</ForeName><Initials>ZX</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiao-Ke</ForeName><Initials>XK</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuai</LastName><ForeName>Zong-Wen</ForeName><Initials>ZW</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Sha-Sha</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Teaching Center for Preventive Medicine, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">causal relationship</Keyword><Keyword MajorTopicYN="N">genetic association</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37275906</ArticleId><ArticleId IdType="pmc">PMC10232808</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1183570</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, et al. . COVID-19: coronavirus vaccine development updates. Front Immunol (2020) 11:602256. doi:&#xa0;10.3389/fimmu.2020.602256</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.602256</ArticleId><ArticleId IdType="pmc">PMC7785583</ArticleId><ArticleId IdType="pubmed">33424848</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses CSGotICoTo . The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol (2020) 5(4):536&#x2013;44. doi:&#xa0;10.1038/s41564-020-0695-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0695-z</ArticleId><ArticleId IdType="pmc">PMC7095448</ArticleId><ArticleId IdType="pubmed">32123347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B, Eser F, Kalem AK, Kaya G, Kaplan B, Kacar D, et al. . Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol (2021) 93(12):6566&#x2013;74. doi:&#xa0;10.1002/jmv.27198</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27198</ArticleId><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol (2020) 16(8):413&#x2013;4. doi:&#xa0;10.1038/s41584-020-0448-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, et al. . Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities. Front Mol Biosci (2022) 9:804109. doi:&#xa0;10.3389/fmolb.2022.804109</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.804109</ArticleId><ArticleId IdType="pmc">PMC9046575</ArticleId><ArticleId IdType="pubmed">35495619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, et al. . Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun (2020) 114:102506. doi:&#xa0;10.1016/j.jaut.2020.102506</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102506</ArticleId><ArticleId IdType="pmc">PMC7296326</ArticleId><ArticleId IdType="pubmed">32563547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonometti R, Sacchi MC, Stobbione P, Lauritano EC, Tamiazzo S, Marchegiani A, et al. . The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci (2020) 24(18):9695&#x2013;7. doi:&#xa0;10.26355/eurrev_202009_23060</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202009_23060</ArticleId><ArticleId IdType="pubmed">33015814</ArticleId></ArticleIdList></Reference><Reference><Citation>Slimani Y, Abbassi R, El Fatoiki FZ, Barrou L, Chiheb S. Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol (2021) 93(2):1184&#x2013;7. doi:&#xa0;10.1002/jmv.26513</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26513</ArticleId><ArticleId IdType="pubmed">32926434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracia-Ramos AE, Saavedra-Salinas M. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? a case-based review. Rheumatol Int (2021) 41(4):799&#x2013;809. doi:&#xa0;10.1007/s00296-021-04794-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04794-7</ArticleId><ArticleId IdType="pmc">PMC7861004</ArticleId><ArticleId IdType="pubmed">33543338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol (2021) 33(2):155&#x2013;62. doi:&#xa0;10.1097/bor.0000000000000776</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/bor.0000000000000776</ArticleId><ArticleId IdType="pmc">PMC7880581</ArticleId><ArticleId IdType="pubmed">33332890</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah N, Rezaei N. Autoimmune complications of COVID-19. J Med Virol (2022) 94(1):54&#x2013;62. doi:&#xa0;10.1002/jmv.27292</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27292</ArticleId><ArticleId IdType="pmc">PMC8661629</ArticleId><ArticleId IdType="pubmed">34427929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zen M, Fuzzi E, Astorri D, Saccon F, Padoan R, Ienna L, et al. . SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun (2020) 112:102502. doi:&#xa0;10.1016/j.jaut.2020.102502</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102502</ArticleId><ArticleId IdType="pmc">PMC7832807</ArticleId><ArticleId IdType="pubmed">32527675</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi G, Bettiol A, Mattioli I, Silvestri E, Di Scala G, Urban ML, et al. . SARS-CoV-2 infection among patients with systemic autoimmune diseases. Autoimmun Rev (2020) 19(7):102575. doi:&#xa0;10.1016/j.autrev.2020.102575</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102575</ArticleId><ArticleId IdType="pmc">PMC7200134</ArticleId><ArticleId IdType="pubmed">32376395</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami Mansoor S, Ghasemi-Kasman M. Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients. J Med Virol (2021) 93(3):1314&#x2013;9. doi:&#xa0;10.1002/jmv.26593</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26593</ArticleId><ArticleId IdType="pmc">PMC7675642</ArticleId><ArticleId IdType="pubmed">33044760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med (2020) 172(11):Itc81&#x2013;itc96. doi:&#xa0;10.7326/aitc202006020</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/aitc202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan L, O'Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet (2019) 393(10188):2332&#x2013;43. doi:&#xa0;10.1016/s0140-6736(19)30237-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocampo-Piraquive V, Nieto-Aristiz&#xe1;bal I, Ca&#xf1;as CA, Tob&#xf3;n GJ. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol (2018) 14(12):1043&#x2013;53. doi:&#xa0;10.1080/1744666x.2018.1538789</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666x.2018.1538789</ArticleId><ArticleId IdType="pubmed">30338717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Choi SJ, Ji JD, Song GG. Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus (2016) 25(7):727&#x2013;34. doi:&#xa0;10.1177/0961203315627202</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315627202</ArticleId><ArticleId IdType="pubmed">26811368</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet (2019) 393(10188):2344&#x2013;58. doi:&#xa0;10.1016/s0140-6736(19)30546-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(19)30546-x</ArticleId><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Li M, Liu L, Wang Z, Wang Y, Zhao J, et al. . Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev (2021) 20(1):102691. doi:&#xa0;10.1016/j.autrev.2020.102691</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102691</ArticleId><ArticleId IdType="pubmed">33190803</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez GA, Gerosa M, Beretta L, Bellocchi C, Argolini LM, Moroni L, et al. . COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients. Semin Arthritis Rheumatol (2020) 50(5):1150&#x2013;7. doi:&#xa0;10.1016/j.semarthrit.2020.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.06.012</ArticleId><ArticleId IdType="pmc">PMC7836639</ArticleId><ArticleId IdType="pubmed">32927376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez GA, Moroni L, Della-Torre E, Gerosa M, Beretta L, Bozzolo EP, et al. . Systemic lupus erythematosus and COVID-19: what we know so far. Ann Rheum Dis (2020) 82(3):e73. doi:&#xa0;10.1136/annrheumdis-2020-218601</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218601</ArticleId><ArticleId IdType="pubmed">32859611</ArticleId></ArticleIdList></Reference><Reference><Citation>Favalli EG, Gerosa M, Murgo A, Caporali R. Are patients with systemic lupus erythematosus at increased risk for COVID-19? Ann Rheum Dis (2021) 80(2):e25. doi:&#xa0;10.1136/annrheumdis-2020-217787</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217787</ArticleId><ArticleId IdType="pubmed">32451344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J, Kandane-Rathnayake R, Louthrenoo W, Hoi A, Golder V, Chen YH, et al. . COVID-19 infection in patients with systemic lupus erythematosus: data from the Asia pacific lupus collaboration. Int J Rheum Dis (2020) 23(9):1255&#x2013;7. doi:&#xa0;10.1111/1756-185x.13937</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185x.13937</ArticleId><ArticleId IdType="pmc">PMC7461525</ArticleId><ArticleId IdType="pubmed">32841510</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko EJ. Observational research&#x2013;opportunities and limitations. J Diabetes Complications (2013) 27(6):642&#x2013;8. doi:&#xa0;10.1016/j.jdiacomp.2013.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC3818421</ArticleId><ArticleId IdType="pubmed">24055326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Zhang Y, Liu J, Yang Y, Fang W, Hong S, et al. . Education and lung cancer: a mendelian randomization study. Int J Epidemiol (2019) 48(3):743&#x2013;50. doi:&#xa0;10.1093/ije/dyz121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyz121</ArticleId><ArticleId IdType="pubmed">31219597</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S. Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol (2003) 32(1):1&#x2013;22. doi:&#xa0;10.1093/ije/dyg070</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyg070</ArticleId><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Baird D, Borges MC, Bowden J, Hemani G, Haycock P, et al. . Recent developments in mendelian randomization studies. Curr Epidemiol Rep (2017) 4(4):330&#x2013;45. doi:&#xa0;10.1007/s40471-017-0128-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40471-017-0128-6</ArticleId><ArticleId IdType="pmc">PMC5711966</ArticleId><ArticleId IdType="pubmed">29226067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekula P, Del Greco MF, Pattaro C, K&#xf6;ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol (2016) 27(11):3253&#x2013;65. doi:&#xa0;10.1681/asn.2016010098</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/asn.2016010098</ArticleId><ArticleId IdType="pmc">PMC5084898</ArticleId><ArticleId IdType="pubmed">27486138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui LL, Nelson EAS, Lin SL, Zhao JV. The role of vitamin c in pneumonia and COVID-19 infection in adults with European ancestry: a mendelian randomisation study. Eur J Clin Nutr (2021) 30:1&#x2013;4. doi:&#xa0;10.1038/s41430-021-00993-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-021-00993-4</ArticleId><ArticleId IdType="pmc">PMC8404179</ArticleId><ArticleId IdType="pubmed">34462559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. . Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet (2015) 47(12):1457&#x2013;64. doi:&#xa0;10.1038/ng.3434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int J Epidemiol (2015) 44(2):512&#x2013;25. doi:&#xa0;10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet (2018) 50(5):693&#x2013;8. doi:&#xa0;10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med (2015) 34(21):2926&#x2013;40. doi:&#xa0;10.1002/sim.6522</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6522</ArticleId><ArticleId IdType="pubmed">25950993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundar Shrestha D, Love R. Long COVID patient symptoms and its evaluation and management. JNMA J Nepal Med Assoc (2021) 59(240):823&#x2013;31. doi:&#xa0;10.31729/jnma.6355</Citation><ArticleIdList><ArticleId IdType="doi">10.31729/jnma.6355</ArticleId><ArticleId IdType="pmc">PMC9107834</ArticleId><ArticleId IdType="pubmed">34508486</ArticleId></ArticleIdList></Reference><Reference><Citation>Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol (2020) 11:589474. doi:&#xa0;10.3389/fimmu.2020.589474</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589474</ArticleId><ArticleId IdType="pmc">PMC7661632</ArticleId><ArticleId IdType="pubmed">33193418</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Shen G, Yang H, Huang A, Chen X, Dong L, et al. . COVID-19 in patients with rheumatic disease in hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol (2020) 2(9):e557&#x2013;64. doi:&#xa0;10.1016/s2665-9913(20)30227-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2665-9913(20)30227-7</ArticleId><ArticleId IdType="pmc">PMC7333992</ArticleId><ArticleId IdType="pubmed">32838309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol (2020) 215:108410. doi:&#xa0;10.1016/j.clim.2020.108410</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108410</ArticleId><ArticleId IdType="pmc">PMC7139239</ArticleId><ArticleId IdType="pubmed">32276140</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama E, Suarez-Fueyo A, Bradley SJ, Mizui M, Marin AV, Mulki L, et al. . The CD38/NAD/SIRTUIN1/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep (2020) 30(1):112&#x2013;23. doi:&#xa0;10.1016/j.celrep.2019.12.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.014</ArticleId><ArticleId IdType="pmc">PMC7577012</ArticleId><ArticleId IdType="pubmed">31914379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res (2021) 232:13&#x2013;36. doi:&#xa0;10.1016/j.trsl.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7749645</ArticleId><ArticleId IdType="pubmed">33352298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. . Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama (2020) 324(13):1330&#x2013;41. doi:&#xa0;10.1001/jama.2020.17023</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17023</ArticleId><ArticleId IdType="pmc">PMC7489434</ArticleId><ArticleId IdType="pubmed">32876694</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanou A, Sawalha AH. SARS-CoV-2 and systemic lupus erythematosus. Curr Rheumatol Rep (2021) 23(2):8. doi:&#xa0;10.1007/s11926-020-00973-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-020-00973-w</ArticleId><ArticleId IdType="pmc">PMC7842169</ArticleId><ArticleId IdType="pubmed">33511495</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>